Berita Terbaru             -  Good Pharmacovigilance Practice Workshop            -  INFORMASI AWAL UNTUK TENAGA PROFESIONAL KESEHATAN TERKAIT KEAMANAN PRODUK YANG MENGANDUNG BAHAN AKTIF RANITIDIN            -  INFORMASI AWAL UNTUK TENAGA PROFESIONAL KESEHATAN TERKAIT KEAMANAN PRODUK YANG MENGANDUNG BAHAN AKTIF RANITIDIN            -  Tecentriq (Atezolizumab) and New Important Identified Risk of Immune-Related Myositis            -  Actemra® (Tocilizumab) and Risk of Hepatotoxicity

Safety Communication

Safety Alert : High Dose Loperamide and The Risk of Serious Heart Problems

 29 Jul 2016

 Read More

Safety Alert : Interferon Beta and The Risk of Thrombotic Microangiopathy (TMA) & Nephrotic

 19 Jul 2016

 Read More

Safety Alert : Tramadol and The Risk of Respiratory Depression in Children

 15 Jul 2016

 Read More

Safety Update Levonorgestrel IUS & Copper IUD and Risk of Uterus Perforation

 15 Jun 2016

 Read More

Safety Alert : The Risk of Birth Defect and Spontaneous Abortions when Pregnant Women were Exposed to Mycophenolate

 27 May 2016

 Read More

Recent Post

Polling

How do you think the content and appearance of this website?
  • 39.27%
    Very Interesting
  • 28.31%
    Interesting
  • 13.7%
    Quite Interesting
  • 12.33%
    Not InterestingNot Interesting

© Copyright 2019 BPOM - Indonesia. All Rights Reserved.

How do you think the content and appearance of this website?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?